Literature DB >> 17720157

Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions.

Sunao Sugita1, Yuri Futagami, Shintaro Horie, Manabu Mochizuki.   

Abstract

The ocular pigment epithelial (PE) cells convert T cells into T regulators (Tregs) in vitro. The PE-induced Tregs fully suppress activation of bystander responder T cells. Iris PE (IPE) cells from anterior segment in the eye produce costimulatory molecules and transforming growth factor beta (TGFbeta) that is delivered to CD8(+) Tregs. We have now examined whether T cells exposed to cultured IPE express CD25 and Foxp3, and to determine if the CD25(+) IPE-exposed T cells display regulatory functions in vitro. We have found that cultured B7-2(+) IPE converted CTLA-4(+) T cells into CD25(+) Tregs that suppress the activation of bystander T cells. The CD8(+) IPE-induced Tregs constitutively expressed CD25. Through TGFbeta-TGFbeta receptor interactions, the IPE converted these T cells into CD25(+) Tregs that express Foxp3 transcripts. The CD8(+) IPE-induced Tregs produced immunoregulatory cytokines, e.g., interleukin-10 and TGFbeta. In addition, IPE-exposed T cells that downregulated Foxp3 mRNA failed to acquire the regulatory function. In conclusion, ocular pigment epithelial cells convert CD8(+) T cells into CD25(+) Tregs by inducing the transcription factor Foxp3. Thus, T cells that encounter ocular parenchymal cells participate in the T-cell suppression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720157     DOI: 10.1016/j.exer.2007.07.015

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  11 in total

1.  CD8+ regulatory T cells are responsible for GAD-IgG gene-transferred tolerance induction in NOD mice.

Authors:  Renxi Wang; Gencheng Han; Lun Song; Jianan Wang; Guojiang Chen; Ruonan Xu; Ming Yu; Jiahua Qian; Beifen Shen; Yan Li
Journal:  Immunology       Date:  2008-06-20       Impact factor: 7.397

Review 2.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

Review 3.  Treating autoimmune disease by targeting CD8(+) T suppressor cells.

Authors:  Christine Konya; Jorg J Goronzy; Cornelia M Weyand
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

4.  Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.

Authors:  Jennifer D Bright; Heather N Schultz; Jennifer A Byrne; Robert K Bright
Journal:  Oncoimmunology       Date:  2013-05-21       Impact factor: 8.110

5.  CD25+CD127+Foxp3- Cells Represent a Major Subpopulation of CD8+ T Cells in the Eye Chambers of Normal Mice.

Authors:  Tomasz Maślanka; Natalia Ziółkowska; Hubert Ziółkowski; Joanna Małaczewska
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 6.  Immune Privilege and Eye-Derived T-Regulatory Cells.

Authors:  Hiroshi Keino; Shintaro Horie; Sunao Sugita
Journal:  J Immunol Res       Date:  2018-05-20       Impact factor: 4.818

Review 7.  Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease.

Authors:  Sabrina Ceeraz; Charlotte R Thompson; Richard Beatson; Ernest H Choy
Journal:  Cells       Date:  2021-11-01       Impact factor: 6.600

8.  Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance.

Authors:  Chitavi D Maulloo; Shijie Cao; Elyse A Watkins; Michal M Raczy; Ani S Solanki; Mindy Nguyen; Joseph W Reda; Ha-Na Shim; D Scott Wilson; Melody A Swartz; Jeffrey A Hubbell
Journal:  Front Immunol       Date:  2021-09-24       Impact factor: 7.561

9.  Type II collagen induces peripheral tolerance in BALB/c mice via the generation of CD8+ T regulatory cells.

Authors:  Shukkur M Farooq; Hossam M Ashour
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

10.  Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras.

Authors:  Hui Wang; Yanping Yang; Guanjun Wang; Shumei Wang; Beow Yong Yeap; Megan Sykes; Yong-Guang Yang
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.